In contrast, nodal involvement on final pathology after upfront surgery was observed in 19.1 %, which is in line with findings from others where nodal involvement after upfront surgery in HER2+ T1-2N0 BC ranges from 19.8 % to 25.3 %. Here, ERBB2 is linked to breast cancer.